Balanced Alpha/Beta Blockade of Adrenoceptors / Balancierte Blockade von Alpha- und Beta-Adrenozeptoren : A rational therapeutic concept in the treatment of hypertension and coronary heart disease / Ein rationales Konzept zur Behandlung der Hypertonie und

Front Matter....Pages I-VIII Front Matter....Pages 1-1 Das ideale Antihypertensivum — Wunschdenken und Wirklichkeit....Pages 3-15 The Pharmacodynamics of Alpha and Beta Blockade....Pages 17-24 Zur Chronopharmakologie von Adrenozeptorenblockem....Pages 25-32 The Response of Plasma Catecholamines to Receptor Antagonists....Pages 33-41 Front Matter....Pages 43-43 The Clinical Profiles of Long Term Labetalol Therapy....Pages 45-50 Beta-Blocker Induced Changes in the Cholesterol: HDL-Cholesterol Ratio and Risk of Coronary Heart Disease....Pages 51-61 Lipid-Stoffwechsel unter Beta-Rezeptoren-Blockade — klinische Konsequenzen....Pages 63-72 A Controlled Comparison of the Peripheral Vasoconstrictor Effects of Labetalol with a Conventional Beta-Blocker in Raynaud’s Phenomenon....Pages 73-78 Pharmacokinetic Glossary of Labetalol....Pages 79-83 Front Matter....Pages 85-85 Änderung der Hämodynamik und die Pharmakotherapie des Hochdrucks....Pages 87-102 Haemodynamic Responses to Combined Alpha-Beta-Receptor Blockade with Labetalol in Relation to the Pathophysiological Mechanisms of Hypertension....Pages 103-111 Haemodynamic Stress Reaction in Essential Hypertension and Effect of a Combined α- and β-Blockade....Pages 113-120 Combined Alpha/Beta Blockade with Acebutolol and Prazosin....Pages 121-130 Clinical Pharmacology of Labetalol in Elderly Hypertensives....Pages 131-141 On the Rationale of Combined Alpha/Beta Blockade (Labetalol) in the Treatment of Hypertension in Pregnancy and the Maintenance of Intra-Uterine Fetal Growth....Pages 143-146 Front Matter....Pages 149-149 The Concept of Combined Alpha-Beta-Blockade in Coronary Heart Disease....Pages 151-159 Pathophysiological Mechanisms of Alpha-Adrenoceptor Stimulation in the Ischemic Heart....Pages 161-170 Beta-Adrenoceptor Blockers, Calcium Antagonists and Combined Alpha-Beta-Receptor Blockade in Coronary Heart Disease: Haemodynamic Profiles....Pages 171-177 Oral Beta and Alpha Blockade (Labetalol) in the Management of Stable Angina Pectoris in Normotensive Patients — A Preliminary Report....Pages 179-188 The Use of Labetalol for Acute Myocardial Infarction in Normotensive Patients....Pages 189-196 Front Matter....Pages 149-149 Effects of Alpha-Beta Blockade on Cardiac Performance in Hypertension Complicating Myocardial Infarction....Pages 197-205 Back Matter....Pages 211-216